Associated Papers
Characterization of ADME Gene Variation in Colombian Population by Exome Sequencing.
Silgado-Guzmán DF et al.
Frontiers in Pharmacology, 2022
35846994 (PubMed )
Supplement: Table1.xlsx › Hoja1
Polymorphisms of Dopamine Receptor Genes and Parkinson's Disease: Clinical Relevance and Future Perspectives.
Magistrelli L et al.
International Journal of Molecular Sciences, 2021
Clinical Implementation of Pharmacogenetic Decision Support Tools for Antidepressant Drug Prescribing.
Zeier Z et al.
The American Journal of Psychiatry, 2018
Cabergoline and prolactinomas: lack of association between DRD2 polymorphisms and response to treatment.
Bueno C et al.
Pituitary, 2017
Does DRD2 polymorphism influence the clinical characteristics of prolactinoma?
Ilhan M et al.
Annales D'endocrinologie, 2015
D2 receptor genetic variation and clinical response to antipsychotic drug treatment: a meta-analysis.
Zhang JP et al.
The American Journal of Psychiatry, 2010
Pharmacogenetics of D2 dopamine receptor gene in prolactin-secreting pituitary adenomas.
Filopanti M et al.
Expert Opinion on Drug Metabolism & Toxicology, 2010
Association between dopaminergic genes (SLC6A3 and DRD2) and stuttering among Han Chinese.
Lan J et al.
Journal of Human Genetics, 2009
Association of the dopamine D2 receptor gene with alcohol dependence: haplotypes and subgroups of alcoholics as key factors for understanding receptor function.
Kraschewski A et al.
Pharmacogenetics and Genomics, 2009
The relationship between the therapeutic response to risperidone and the dopamine D2 receptor polymorphism in Chinese schizophrenia patients.
Xing Q et al.
The International Journal of Neuropsychopharmacology, 2007
Select a paper to view details